Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda C Foks

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 11, 2021
Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP MiceEnchen Zhou, Zhuang Li, Hiroyuki Nakashima, et al.
Atherosclerosis|May 31, 2022
Tim-1 mucin domain-mutant mice display exacerbated atherosclerosisHidde Douna, Virginia Smit, Gijs H M van Puijvelde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2015
Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosisVanessa Frodermann, Gijs H M van Puijvelde, Laura Wierts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Interference of the CD30-CD30L pathway reduces atherosclerosis developmentAmanda C Foks, Ilze Bot, Vanessa Frodermann, et al.
Scientific Reports|November 24, 2019
Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse modelFrank H Schaftenaar, Jacob Amersfoort, Hidde Douna, et al.
Cardiovascular Research|May 29, 2016
CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient miceAmanda C Foks, Gijs H M Van Puijvelde, Jolien Wolbert, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2016
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceAmanda C Foks, Daniel Engelbertsen, Felicia Kuperwaser, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2022
A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsisFeiyan Liu, Linda B S Aulin, Sebastiaan S A Kossen, et al.
Scientific Reports|November 2, 2022
Blockade of the BLT1-LTB<sub>4</sub> axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr<sup>-/-</sup> miceMarie A C Depuydt, Femke D Vlaswinkel, Esmeralda Hemme, et al.
Frontiers in Cardiovascular Medicine|November 18, 2021
Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient MiceHendrika W Grievink, Virginia Smit, Robin A F Verwilligen, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Arteriosclerosis, Thrombosis, and Vascular Biology|February 11, 2021
Hepatic Scavenger Receptor Class B Type 1 Knockdown Reduces Atherosclerosis and Enhances the Antiatherosclerotic Effect of Brown Fat Activation in APOE*3-Leiden.CETP MiceEnchen Zhou, Zhuang Li, Hiroyuki Nakashima, et al.
Atherosclerosis|May 31, 2022
Tim-1 mucin domain-mutant mice display exacerbated atherosclerosisHidde Douna, Virginia Smit, Gijs H M van Puijvelde, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2015
Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosisVanessa Frodermann, Gijs H M van Puijvelde, Laura Wierts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2012
Interference of the CD30-CD30L pathway reduces atherosclerosis developmentAmanda C Foks, Ilze Bot, Vanessa Frodermann, et al.
Scientific Reports|November 24, 2019
Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse modelFrank H Schaftenaar, Jacob Amersfoort, Hidde Douna, et al.
Cardiovascular Research|May 29, 2016
CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient miceAmanda C Foks, Gijs H M Van Puijvelde, Jolien Wolbert, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 30, 2016
Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient MiceAmanda C Foks, Daniel Engelbertsen, Felicia Kuperwaser, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2022
A system pharmacology Boolean network model for the TLR4-mediated inflammatory response in early sepsisFeiyan Liu, Linda B S Aulin, Sebastiaan S A Kossen, et al.
Scientific Reports|November 2, 2022
Blockade of the BLT1-LTB<sub>4</sub> axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr<sup>-/-</sup> miceMarie A C Depuydt, Femke D Vlaswinkel, Esmeralda Hemme, et al.
Frontiers in Cardiovascular Medicine|November 18, 2021
Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient MiceHendrika W Grievink, Virginia Smit, Robin A F Verwilligen, et al.
Pageof 5